Health Conditions Related to Genetic Changes
Neurohypophyseal diabetes insipidus
At least 60 mutations in the AVP gene have been found to cause neurohypophyseal diabetes insipidus. Most of these mutations change single protein building blocks (amino acids) in the preprohormone or result in the production of an abnormally short version of this molecule. Studies suggest that the altered preprohormone becomes trapped inside the cells where it is produced instead of being transported to the pituitary gland. As the defective molecule builds up over time, it damages and ultimately kills these cells. The resulting shortage of ADH prevents the kidneys from reabsorbing water as they should, and the body makes excessive amounts of urine. These problems with water balance are characteristic of neurohypophyseal diabetes insipidus.
More About This Health ConditionOther Names for This Gene
- ADH
- antidiuretic hormone
- ARVP
- AVP-NPII
- AVRP
- NEU2_HUMAN
- neurohypophyseal
- vasopressin-neurophysin 2-copeptin
- vasopressin-neurophysin 2-copeptin preproprotein
- vasopressin-neurophysin II-copeptin
- VP
Additional Information & Resources
Tests Listed in the Genetic Testing Registry
Scientific Articles on PubMed
Catalog of Genes and Diseases from OMIM
References
- Christensen JH, Rittig S. Familial neurohypophyseal diabetes insipidus--an update. Semin Nephrol. 2006 May;26(3):209-23. doi: 10.1016/j.semnephrol.2006.03.003. Citation on PubMed
- Christensen JH, Siggaard C, Corydon TJ, deSanctis L, Kovacs L, Robertson GL, Gregersen N, Rittig S. Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis. Eur J Hum Genet. 2004 Jan;12(1):44-51. doi: 10.1038/sj.ejhg.5201086. Citation on PubMed
- Grant FD, Ahmadi A, Hosley CM, Majzoub JA. Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant. J Clin Endocrinol Metab. 1998 Nov;83(11):3958-64. doi: 10.1210/jcem.83.11.5278. Citation on PubMed
- Ito M, Mori Y, Oiso Y, Saito H. A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus. J Clin Invest. 1991 Feb;87(2):725-8. doi: 10.1172/JCI115052. Citation on PubMed or Free article on PubMed Central
- Nagasaki H, Ito M, Yuasa H, Saito H, Fukase M, Hamada K, Ishikawa E, Katakami H, Oiso Y. Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus. J Clin Endocrinol Metab. 1995 Apr;80(4):1352-6. doi: 10.1210/jcem.80.4.7714110. Citation on PubMed
- Repaske DR, Summar ML, Krishnamani MR, Gultekin EK, Arriazu MC, Roubicek ME, Blanco M, Isaac GB, Phillips JA 3rd. Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab. 1996 Jun;81(6):2328-34. doi: 10.1210/jcem.81.6.8964872. Citation on PubMed
- Rittig S, Robertson GL, Siggaard C, Kovacs L, Gregersen N, Nyborg J, Pedersen EB. Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Hum Genet. 1996 Jan;58(1):107-17. Citation on PubMed or Free article on PubMed Central
- Siggaard C, Rittig S, Corydon TJ, Andreasen PH, Jensen TG, Andresen BS, Robertson GL, Gregersen N, Bolund L, Pedersen EB. Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation. J Clin Endocrinol Metab. 1999 Aug;84(8):2933-41. doi: 10.1210/jcem.84.8.5869. Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.




